Arcutis Biotherapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +1,517.1% | +229.7% | +91.3% | |
| – | – | – | +133.3% | +67.7% | -1.2% | +561.4% | +283.6% | +91.8% | |
| – | – | – | – | – | – | +1,762.9% | +224.8% | +91.3% | |
| – | +425.9% | +103.6% | +215.7% | +26.2% | +25.3% | -39.4% | -30.9% | +0.8% | |
| – | +158.3% | +268.2% | +222.8% | +185.8% | +100.3% | +42.1% | +28.2% | +23.4% | |
| – | +380.6% | +117.6% | +217.2% | +51.6% | +47.5% | -2.9% | +3.4% | +15.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +3,347.6% | +89.8% | -8.6% | -55.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | -464.3% | – | – | -68.3% | -79.2% | +81.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.